AI drug discovery becomes a bottleneck trade: Twist orders up triple digits, GenScript hits 8,000 designs a day

QuanquanGu · x · 2026-10-05

Quanquan Gu highlights a Robonomics essay arguing AI drug discovery (AIDD) is becoming a bottleneck trade, alongside his own vision at Geodesic: design in silico, validate in the wet lab, feed experimental data back as semi-synthetic training data, and loop — making the wet lab part of the learning algorithm.

Key points:

Original post →

More from AGI Musings

AGI Musings channel →